Cannula provoked upper extremity superficial vein thrombophlebitis: are we overtreating?

Cannula provoked upper extremity superficial vein thrombophlebitis (UESVT) is common. Retrospective audit of 93 consecutive patients, 51% male, median age 57 years (range 20–91), with symptomatic UESVT revealed varied management including symptomatic management (37%), prophylactic (37%) and higher d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuen, Hiu L. A., Fang, Wendy, Tran, Huyen, Chunilal, Sanjeev D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828520/
https://www.ncbi.nlm.nih.gov/pubmed/36326238
http://dx.doi.org/10.1111/imj.15951
Descripción
Sumario:Cannula provoked upper extremity superficial vein thrombophlebitis (UESVT) is common. Retrospective audit of 93 consecutive patients, 51% male, median age 57 years (range 20–91), with symptomatic UESVT revealed varied management including symptomatic management (37%), prophylactic (37%) and higher dose anticoagulation (27%). There was 2% (95% confidence interval (CI) 0–7.6) thrombus extension and 1% (95% CI 0–5.9) major bleeding, both limited to cancer. We argue anticoagulation is unnecessary in most UESVT patients.

Ejemplares similares